Venkatesh Pilla Reddy

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 16

Top Topics

Dna Damage Response

Monoclonal Antibody

Metastatic Renal Cell Carcinoma

Coronavirus Disease

Top Venues

CPT: pharmacometrics & systems pharmacology

Science translational medicine

British journal of clinical pharmacology

Biopharmaceutics & drug disposition

This page only lists publications with an associated author ORCID identifier.

Publications

Jaidip Gill, Marie Moullet, Anton Martinsson, Filip Miljković, Beth Williamson, Rosalinda H Arends, Venkatesh Pilla Reddy
Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactions. CPT: pharmacometrics & systems pharmacology (2022)
Jaidip Gill, Marie Moullet, Anton Martinsson, Filip Miljković, Beth Williamson, Rosalinda H Arends, Venkatesh Pilla Reddy
Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction prediction. CPT: pharmacometrics & systems pharmacology (2022)
Yueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, Michael E Abram, Anastasia A Aksyuk, Seme Diallo, Daniel J Flores, Elizabeth J Kelly, Kuishu Ren, Richard Roque, Kim Rosenthal, Katie Streicher, Kevin M Tuffy, Nicholas J Bond, Owen Cornwell, Jerome Bouquet, Lily I Cheng, James Dunyak, Yue Huang, Anton I Rosenbaum, Venkatesh Pilla Reddy, Hanne A Elyard, Robert H Carnahan, James E Crowe, Ana I Kuehne, Andrew S Herbert, John M Dye, Helen Bright, Nicole L Kallewaard, Menelas N Pangalos, Mark T Esser
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans. Science translational medicine 14 (635) (2022)
Rachel Bender Ignacio, David Alain Wohl, Rosalin Arends, Venkatesh Pilla Reddy, Ying Mu, Arzhang Cyrus Javan, Michael D Hughes, Joseph J Eron, Judith S Currier, Davey M Smith, Kara W Chew, Michael Gibbs, Courtney V Fletcher
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection. Clinical pharmacology and therapeutics 112 (6) (2022)
Inez Lam, Venkatesh Pilla Reddy, Kathryn Ball, Rosalinda H Arends, Feilim Mac Gabhann
Development of and insights from systems pharmacology models of antibody-drug conjugates. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)
Venkatesh Pilla Reddy
Special issue on applications of modeling and simulation in pharmaceutical drug development. Biopharmaceutics & drug disposition 42 (4) (2021)
Beth Williamson, Venkatesh Pilla Reddy
Blood retinal barrier and ocular pharmacokinetics: Considerations for the development of oncology drugs. Biopharmaceutics & drug disposition 42 (4) (2021)
Erica Banks, Michael Grondine, Deepa Bhavsar, Evan Barry, Jason G Kettle, Venkatesh Pilla Reddy, Crystal Brown, Haiyun Wang, Jerome T Mettetal, Teresa Collins, Oladipupo Adeyemi, Ross Overman, Deborah Lawson, Alexander R Harmer, Corinne Reimer, Lisa Drew, Martin J Packer, Sabina Cosulich, Rhys D O Jones, Wenlin Shao, David Wilson, Sylvie M Guichard, Stephen E Fawell, Rana Anjum
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors. Science translational medicine 12 (541) (2021)
Xian Pan, Shinji Yamazaki, Sibylle Neuhoff, Mian Zhang, Venkatesh Pilla Reddy
Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substrates. CPT: pharmacometrics & systems pharmacology (2021)
Venkatesh Pilla Reddy, Heeseung Jo, Sibylle Neuhoff
Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labelling. British journal of clinical pharmacology 87 (10) (2021)
Venkatesh Pilla Reddy, Adrian J Fretland, Diansong Zhou, Shringi Sharma, Buyun Chen, Karthick Vishwanathan, Dermot F McGinnity, Yan Xu, Joseph A Ware
Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors. Cancer chemotherapy and pharmacology 88 (3) (2021)
Balakrishna Koneru, Ahsan S Farooqi, Thinh Hoang Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A Burrow, Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine B Cadogan, Stephen T Durant, C Patrick Reynolds
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156. Science translational medicine 13 (607) (2021)
Venkatesh Pilla Reddy, Rana Anjum, Michael Grondine, Aaron Smith, Deepa Bhavsar, Evan Barry, Sylvie M Guichard, Wenlin Shao, Jason G Kettle, Crystal Brown, Erica Banks, Rhys D O Jones
The Pharmacokinetic-Pharmacodynamic (PKPD) Relationships of AZD3229, a Novel and Selective Inhibitor of KIT, in a Range of Mouse Xenograft Models of GIST. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Mailys De Sousa Mendes, Alexandra L Orton, Helen E Humphries, Barry Jones, Iain Gardner, Sibylle Neuhoff, Venkatesh Pilla Reddy
A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates. Drug metabolism and disposition: the biological fate of chemicals 48 (11) (2020)
Venkatesh Pilla Reddy, Eman El-Khateeb, Heeseung Jo, Natalie Giovino, Emily Lythgoe, Shringi Sharma, Weifeng Tang, Masoud Jamei, Amin Rastomi-Hodjegan
Pharmacokinetics under the COVID-19 storm. British journal of clinical pharmacology (2020)
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok, Thomas A Hunt, Kurt G Pike, Joanne Wilson, Aaron Smith, Nicola Colclough, Venkatesh Pilla Reddy, Andrew Sykes, Annika Janefeldt, Peter Johnström, Katarina Varnäs, Akihiro Takano, Stephanie Ling, Jonathan Orme, Jonathan Stott, Caroline Roberts, Ian Barrett, Gemma Jones, Martine Roudier, Andrew Pierce, Jasmine Allen, Jenna Kahn, Amrita Sule, Jeremy Karlin, Anna Cronin, Melissa Chapman, Kristoffer Valerie, Ruth Illingworth, Martin Pass
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Science advances 4 (6) (2018)